|
HY-N5132-500mg
|
MedChemexpress LLC
|
(-)-Fenchone [CAS 7787-20-4]
|
|
|
|
|
HY-N5132-1mL
|
MedChemexpress LLC
|
(-)-Fenchone [CAS 7787-20-4] (10mM in DMSO)
|
|
|
|
|
HY-110000-1mg
|
MedChemexpress LLC
|
(+)-PD 128907 hydrochloride [CAS 300576-59-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110000-10mg
|
MedChemexpress LLC
|
(+)-PD 128907 hydrochloride [CAS 300576-59-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110000-25mg
|
MedChemexpress LLC
|
(+)-PD 128907 hydrochloride [CAS 300576-59-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110000-5mg
|
MedChemexpress LLC
|
(+)-PD 128907 hydrochloride [CAS 300576-59-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110000-50mg
|
MedChemexpress LLC
|
(+)-PD 128907 hydrochloride [CAS 300576-59-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110000-1mL
|
MedChemexpress LLC
|
(+)-PD 128907 hydrochloride [CAS 300576-59-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100583A-10mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-100mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-200mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-25mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-5mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-50mg
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100583A-1mL
|
MedChemexpress LLC
|
(�)-Equol [CAS 94105-90-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-107721-10mg
|
MedChemexpress LLC
|
(�)-J-113397 [CAS 217461-40-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107721-25mg
|
MedChemexpress LLC
|
(�)-J-113397 [CAS 217461-40-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107721-5mg
|
MedChemexpress LLC
|
(�)-J-113397 [CAS 217461-40-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-107721-50mg
|
MedChemexpress LLC
|
(�)-J-113397 [CAS 217461-40-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N12253-1mg
|
MedChemexpress LLC
|
(19R)-13-Deoxy-19-hydroxyenmein [CAS 16763-48-7]
|
|
|
|
|
HY-108501-1mg
|
MedChemexpress LLC
|
(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 [CAS 208706-12-1]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-109001A-10mg
|
MedChemexpress LLC
|
(1S,2R)-Alicapistat [CAS 2221010-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-109001A-25mg
|
MedChemexpress LLC
|
(1S,2R)-Alicapistat [CAS 2221010-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-109001A-5mg
|
MedChemexpress LLC
|
(1S,2R)-Alicapistat [CAS 2221010-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-109001A-50mg
|
MedChemexpress LLC
|
(1S,2R)-Alicapistat [CAS 2221010-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
